CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Shares	Cumulative Common Distributions	Additional Paid in Capital	Cumulative Net Income	Cumulative Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2023		165,769,595
Beginning balance at Dec. 31, 2023	$ 1,226,133	$ 1,658	$ (5,805,816)	$ 4,557,473	$ 2,470,500	$ 2,318
Increase (Decrease) in Shareholders' Equity
Net loss	(78,383)				(78,383)
Equity interest in investee’s unrealized gains (losses)	(344)					(344)
Common share grants	430			430
Common share repurchases (in shares)		(1,537)
Common share repurchases	(13)			(13)
Distributions	(33,154)		(33,154)
Ending balance (in shares) at Mar. 31, 2024		165,768,058
Ending balance at Mar. 31, 2024	1,114,669	$ 1,658	(5,838,970)	4,557,890	2,392,117	1,974
Beginning balance (in shares) at Dec. 31, 2023		165,769,595
Beginning balance at Dec. 31, 2023	1,226,133	$ 1,658	(5,805,816)	4,557,473	2,470,500	2,318
Increase (Decrease) in Shareholders' Equity
Net loss	(152,233)
Equity interest in investee’s unrealized gains (losses)	(536)
Ending balance (in shares) at Jun. 30, 2024		165,903,837
Ending balance at Jun. 30, 2024	1,008,806	$ 1,659	(5,872,122)	4,559,220	2,318,267	1,782
Beginning balance (in shares) at Mar. 31, 2024		165,768,058
Beginning balance at Mar. 31, 2024	1,114,669	$ 1,658	(5,838,970)	4,557,890	2,392,117	1,974
Increase (Decrease) in Shareholders' Equity
Net loss	(73,850)				(73,850)
Equity interest in investee’s unrealized gains (losses)	(192)					(192)
Common share grants (in shares)		146,040
Common share grants	1,396	$ 1		1,395
Common share repurchases (in shares)		(10,261)
Common share repurchases	(65)			(65)
Distributions	(33,152)		(33,152)
Ending balance (in shares) at Jun. 30, 2024		165,903,837
Ending balance at Jun. 30, 2024	1,008,806	$ 1,659	(5,872,122)	4,559,220	2,318,267	1,782
Beginning balance (in shares) at Dec. 31, 2024		166,636,537
Beginning balance at Dec. 31, 2024	851,873	$ 1,666	(5,906,966)	4,560,334	2,194,974	1,865
Increase (Decrease) in Shareholders' Equity
Net loss	(116,435)				(116,435)
Equity interest in investee’s unrealized gains (losses)	153					153
Common share grants (in shares)		32,490
Common share grants	664			664
Common share repurchases (in shares)		(1,539)
Common share repurchases	(4)			(4)
Common share forfeitures (in shares)		(20,767)
Common share forfeitures	(12)			(12)
Distributions	(1,666)		(1,666)
Ending balance (in shares) at Mar. 31, 2025		166,646,721
Ending balance at Mar. 31, 2025	734,573	$ 1,666	(5,908,632)	4,560,982	2,078,539	2,018
Beginning balance (in shares) at Dec. 31, 2024		166,636,537
Beginning balance at Dec. 31, 2024	851,873	$ 1,666	(5,906,966)	4,560,334	2,194,974	1,865
Increase (Decrease) in Shareholders' Equity
Net loss	(154,594)
Equity interest in investee’s unrealized gains (losses)	$ 308
Common share repurchases (in shares)	(29,956)
Ending balance (in shares) at Jun. 30, 2025		166,860,830
Ending balance at Jun. 30, 2025	$ 695,944	$ 1,669	(5,910,299)	4,562,021	2,040,380	2,173
Beginning balance (in shares) at Mar. 31, 2025		166,646,721
Beginning balance at Mar. 31, 2025	734,573	$ 1,666	(5,908,632)	4,560,982	2,078,539	2,018
Increase (Decrease) in Shareholders' Equity
Net loss	(38,159)				(38,159)
Equity interest in investee’s unrealized gains (losses)	155					155
Common share grants (in shares)		282,975
Common share grants	1,139	$ 3		1,136
Common share repurchases (in shares)		(28,417)
Common share repurchases	(59)			(59)
Common share forfeitures (in shares)		(40,449)
Common share forfeitures	(38)			(38)
Distributions	(1,667)		(1,667)
Ending balance (in shares) at Jun. 30, 2025		166,860,830
Ending balance at Jun. 30, 2025	$ 695,944	$ 1,669	$ (5,910,299)	$ 4,562,021	$ 2,040,380	$ 2,173